Adelaide Research & Scholarship: Search

Search

Results 1-10 of 15 (Search time: 0.003 seconds).

previous
1
2
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2006	Suppression of androgen receptor signaling in prostate cancer cells by an inhibitory receptor variant	Butler, L.; Centenera, M.; Neufing, P.; Buchanan, G.; Choong, C.; Ricciardelli, C.; Saint, K.; Lee, M.; Ochnik, A.; Yang, M.; Brown, M.; Tilley, W.
	2004	Androgen receptor signaling: mechanism of interleukin-6 inhibition	Jia, L.; Choong, C.; Ricciardelli, C.; Kim, J.; Tilley, W.; Coetzee, G.
	2019	A reciprocal feedback between the PDZ binding kinase and androgen receptor drives prostate cancer	Warren, A.; Massie, C.; Watt, K.; Luko, K.; Orafidiya, F.; Selth, L.; Mohammed, H.; Chohan, B.; Menon, S.; Baridi, A.; Zhao, W.; Escriu, C.; Pungsrinont, T.; D Santos, C.; Yang, X.; Taylor, C.; Qureshi, A.; Zecchini, V.; Shaw, G.; Dehm, S.; et al.
	2017	The combination of metformin and valproic acid induces synergistic apoptosis in the presence of p53 and androgen signaling in prostate cancer	Tran, L.N.; Kichenadasse, G.; Butler, L.M.; Centenera, M.M.; Morel, K.L.; Ormsby, R.J.; Michael, M.Z.; Lower, K.M.; Sykes, P.J.
	2016	Computational reconstruction of NFκB pathway interaction mechanisms during prostate cancer	Börnigen, D.; Tyekucheva, S.; Wang, X.; Rider, J.R.; Lee, G.S.; Mucci, L.A.; Sweeney, C.; Huttenhower, C.; Przytycka, T.M.
	2023	Integrative characterisation of secreted factors involved in intercellular communication between prostate epithelial or cancer cells and fibroblasts	Wu, Y.; Clark, K.C.; Niranjan, B.; Chüeh, A.C.; Horvath, L.G.; Taylor, R.A.; Daly, R.J.
	2021	Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancer	Che, M.; Chaturvedi, A.; Munro, S.A.; Pitzen, S.P.; Ling, A.; Zhang, W.; Mentzer, J.; Ku, S.-Y.; Puca, L.; Zhu, Y.; Bergman, A.M.; Severson, T.M.; Forster, C.; Liu, Y.; Hildebrand, J.; Daniel, M.; Wang, T.-Y.; Selth, L.A.; Hickey, T.; Zoubeidi, A.; et al.
	2014	Nutlin-3a efficacy in sarcoma predicted by transcriptomic and epigenetic profiling	Pishas, K.; Neuhaus, S.; Clayer, M.; Schreiber, A.; Lawrence, D.; Perugini, M.; Whitfield, R.; Farshid, G.; Manavis, J.; Chryssidis, S.; Mayo, B.; Haycox, R.; Ho, K.; Brown, M.; D'Andrea, R.; Evdokiou, A.; Thomas, D.; Desai, J.; Callen, D.; Neilsen, P.
	2018	Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy	Marini, K.D.; Croucher, D.R.; McCloy, R.A.; Vaghjiani, V.; Gonzalez-Rajal, A.; Hastings, J.F.; Chin, V.; Szczepny, A.; Kostyrko, K.; Marquez, C.; Samantha, W.; Jayasekara, N.; Alamgeer, M.; Boolell, V.; Han, J.Z.R.; Waugh, T.; Lee, H.C.; Oakes, S.R.; Kumar, B.; Harrison, C.A.; et al.
	2012	Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: Preclinical evaluation and results of the Phase II DUX Study in chemotherapy-refractory, advanced colorectal cancer	Weickhardt, A.; Price, T.; Chong, G.; Gebski, V.; Pavlakis, N.; Johns, T.; Azad, A.; Skrinos, E.; Fluck, K.; Dobrovic, A.; Salemi, R.; Scott, A.; Mariadason, J.; Tebbutt, N.